• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease.

作者信息

CRAIG J M, MACAULEY J C, WELLER T H, WIRTH P

出版信息

Proc Soc Exp Biol Med. 1957 Jan;94(1):4-12. doi: 10.3181/00379727-94-22841.

DOI:10.3181/00379727-94-22841
PMID:13400856
Abstract
摘要

相似文献

1
Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease.从患有类似巨细胞包涵体病的婴儿中分离出产生核内包涵体的病原体。
Proc Soc Exp Biol Med. 1957 Jan;94(1):4-12. doi: 10.3181/00379727-94-22841.
2
[ELECTRONOPTIC STUDIES ON CYTOMEGALIC NUCLEAR INCLUSIONS].
Frankf Z Pathol. 1964 Apr 28;73:514-9.
3
Generalized cytomegalic inclusion disease in newborn infants.
J Am Med Assoc. 1956 Dec 1;162(14):1305-8. doi: 10.1001/jama.1956.02970310033008.
4
Generalized cytomegalic inclusion disease. A review and a report of the isolation of virus from cases occurring in Johannesburg.
S Afr Med J. 1962 Jan 6;36:8-15.
5
[The virus of cytomegalic inclusion disease. Its isolation in 2 cases. Survival of the patient, without sequelae, in one of these cases. Presence of inclusions in the placenta in a third case].
Arch Fr Pediatr. 1960;17:437-50.
6
Generalized cytomegalic inclusion disease.
J Pediatr. 1957 Aug;51(2):146-56. doi: 10.1016/s0022-3476(57)80171-1.
7
Cytomegalic inclusion-body disease in African infants.非洲婴儿的巨细胞包涵体病
S Afr Med J. 1962 Mar 24;36:228-31.
8
Generalized cytomegalic inclusion disease in a newborn infant.
Acta Pathol Microbiol Scand. 1961;53:65-70. doi: 10.1111/j.1699-0463.1961.tb00385.x.
9
Generalized cytomegalic inclusion disease.
Acta Paediatr (Stockh). 1959 Jul;48:391-6. doi: 10.1111/j.1651-2227.1959.tb16413.x.
10
[Cytomegalic inclusion disease diagnosed in vivo].
Nourrisson. 1959 May-Jun;47:77-90.

引用本文的文献

1
Perspective on the 65-Year Anniversary of the Discovery of Cytomegalovirus.巨细胞病毒发现65周年展望
Viruses. 2025 Jan 9;17(1):80. doi: 10.3390/v17010080.
2
Advances and Challenges in Cytomegalovirus Detection Methods for Liver Transplant Donors.肝移植供体巨细胞病毒检测方法的进展与挑战
Diagnostics (Basel). 2023 Oct 26;13(21):3310. doi: 10.3390/diagnostics13213310.
3
Human Cytomegalovirus Replication and Infection-Induced Syncytia Formation in Labial, Foreskin, and Fetal Lung Fibroblasts.人巨细胞病毒在唇、包皮和胎儿肺成纤维细胞中的复制和感染诱导的合胞体形成。
Viruses. 2021 Nov 24;13(12):2355. doi: 10.3390/v13122355.
4
Insight for Immunotherapy of HCMV Infection.巨细胞病毒感染免疫治疗的新视角。
Int J Biol Sci. 2021 Jul 13;17(11):2899-2911. doi: 10.7150/ijbs.58127. eCollection 2021.
5
Pathogenesis of human cytomegalovirus in the immunocompromised host.免疫功能低下宿主中人巨细胞病毒的发病机制。
Nat Rev Microbiol. 2021 Dec;19(12):759-773. doi: 10.1038/s41579-021-00582-z. Epub 2021 Jun 24.
6
A Novel Strain-Specific Neutralizing Epitope on Glycoprotein H of Human Cytomegalovirus.人巨细胞病毒糖蛋白 H 上的新型株特异性中和表位。
J Virol. 2021 Aug 25;95(18):e0065721. doi: 10.1128/JVI.00657-21.
7
Virus-Driven Carcinogenesis.病毒驱动的致癌作用
Cancers (Basel). 2021 May 27;13(11):2625. doi: 10.3390/cancers13112625.
8
Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation.移植中巨细胞病毒感染的预防、诊断和管理的进展和挑战。
Clin Microbiol Rev. 2020 Oct 28;34(1). doi: 10.1128/CMR.00043-19. Print 2020 Dec 16.
9
Where do we Stand after Decades of Studying Human Cytomegalovirus?经过数十年对人类巨细胞病毒的研究，我们目前处于什么阶段？
Microorganisms. 2020 May 8;8(5):685. doi: 10.3390/microorganisms8050685.
10
Human Cytomegalovirus Congenital (cCMV) Infection Following Primary and Nonprimary Maternal Infection: Perspectives of Prevention through Vaccine Development.原发性和非原发性母体感染后的人巨细胞病毒先天性（cCMV）感染：通过疫苗开发进行预防的前景
Vaccines (Basel). 2020 Apr 23;8(2):194. doi: 10.3390/vaccines8020194.